Page last updated: 2024-11-03

ag 1879 and Burkitt Lymphoma

ag 1879 has been researched along with Burkitt Lymphoma in 1 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cozzi, M1
Giorgi, F1
Marcelli, E1
Pentimalli, F1
Forte, IM1
Schenone, S1
D'Urso, V1
De Falco, G1
Botta, M1
Giordano, A1
Indovina, P1

Other Studies

1 other study available for ag 1879 and Burkitt Lymphoma

ArticleYear
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition.
    Cell cycle (Georgetown, Tex.), 2012, Mar-01, Volume: 11, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Cycle Proteins; Cell L

2012